| Health / Medical Topics |
Multitargeted Tyrosine Kinase Inhibitor MGCD265
An orally bioavailable, small-molecule, multitargeted tyrosine kinase inhibitor with potential antineoplastic activity. Multitargeted tyrosine kinase inhibitor MGCD265 binds to and inhibits the phosphorylation of several receptor tyrosine kinases (RTKs), including the c-Met receptor (hepatocyte growth factor receptor); the Tek/Tie-2 receptor; vascular endothelial growth factor receptor (VEGFR) types 1, 2, and 3; and the macrophage-stimulating 1 receptor (MST1R or RON). Inhibition of these RTKs and their downstream signaling pathways may result in the inhibition of tumor angiogenesis and tumor cell proliferation in tumors overexpressing these RTKs. (NCI Thesaurus)
YOU MAY ALSO LIKE
An orally bioavailable, small-molecule, multitargeted reversible tyrosine kinase inhibitor with potential antineoplastic activity. Multitargeted tyrosine kinase inhibitor JNJ-26483327 binds to and inhibits…
A substance being studied in the treatment of several types of cancer. Multitargeted receptor tyrosine kinase inhibitor ABT-869 blocks the action of…
Having ancestors of several or various races.
A standard file format for transferring non-textual data over the internet.
A cell that can only differentiate to a particular type of cells (e.g. hematopoietic cells or epithelial cells). --2005
A specialized, self-renewing cell in the bone marrow that has the capacity to differentiate into a cell with a particular function, but…
